Furthermore, the expression levels of LAG‐3 protein were significantly different between NSCLC and benign lung tissue samples, suggesting that LAG‐3 could be used as a biomarker for differentiating NSCLC and benign lung tissue. This evidence concerns the gene LAG3 and non-small cell lung carcinoma.